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Background: Liver cancer is one of the most common can-
cers worldwide, particularly in Asia and Africa, where in-
fectious hepatitis and aflatoxin exposures are common. We
conducted a prospective cohort study of liver cancer in
Korea to assess the independent effects and interactions of
smoking, alcohol consumption, and hepatitis B on risk of
mortality from hepatocellular carcinoma. Methods: From a
total of 1 283 112 men and women free of cancer at baseline,
3807 died from liver cancer during follow-up from 1993 to
2002. All participants reported their smoking and alcohol
consumption, and hepatitis B surface antigen (HBsAg) status
was documented for 47.2% of the participants. Relative risk
and 95% confidence intervals (CIs) of mortality from hepa-
tocellular carcinoma were calculated using proportional
hazards models adjusted for age, alcohol drinking, diabetes,
and HBsAg status. Results: Current smoking was associated
with increased risk of mortality from hepatocellular carci-
noma in men (RR  1.4; 95% CI  1.3 to 1.6) but not
women (RR  1.1; CI  0.8 to1.7). The relative risk of
mortality from hepatocellular carcinoma for male HBsAg
carriers was 24.3 (95% CI  21.9 to 26.9) times that in
HBsAg-negative males; the relative risk for HBsAg-positive
women was 54.4 (95% CI  24.8 to119.5). Heavy alcohol
drinking was associated with hepatocellular carcinoma mor-
tality risk in the subgroup of men who were tested for
HBsAg (RR 1.5; 95% CI  1.2 to 2.0). There was no
interaction among smoking, alcohol drinking, and HBsAg in
terms of hepatocellular carcinoma mortality. Conclusion:
Cigarette smoking, heavy alcohol consumption, and HBsAg
were independently associated with increased risk of mor-
tality from hepatocellular carcinoma but did not interact
synergistically. The relatively higher increase in mortality
from hepatocellular carcinoma in HBsAg-seropositive
women compared with men merits further research. [J Natl
Cancer Inst 2004;96:1851–5]
Liver cancer is one of the most common cancers worldwide.
It is particularly widespread in Asia and Africa, where infectious
hepatitis and aflatoxin exposures are common. Established
causal risk factors include hepatitis B infection, dietary aflatoxin
exposure, chronic alcohol consumption, hepatic cirrhosis, and
cigarette smoking, the last of which was recently classified as
causal by the International Agency for Research on Cancer
(IARC) (1). Although many epidemiologic studies have ad-
dressed these and other risk factors, there has been limited
exploration of the combined effects of these exposures, reflect-
ing the limitations posed by the study population size and the
exposure data available in the studies carried out to date. Syn-
ergism among common factors such as hepatitis B infection,
smoking, and alcohol consumption would have substantial pub-
lic health and clinical relevance because it would place some
individuals at extremely high risk. To date, some studies have
provided findings on synergism, but a recent review on smoking
and other factors carried out by the IARC found the evidence to
be inconclusive (1).
We have conducted a prospective cohort study of the causes
of cancer in a cohort of Koreans (the Korean Cancer Prevention
Study) insured by the National Health Insurance Corporation
(2). The cohort is large, numbering more than 1.3 million;
information on smoking and alcohol use is available for all
participants, and information on hepatitis B surface antigen
(HBsAg) is available for approximately half. Follow-up, accom-
plished through record linkage at the national level, is complete,
except for emigrants. In this article, we describe risk for hepa-
tocellular carcinoma in relation to smoking, alcohol use, and
HBsAg during 10 years of follow-up, over which there were
3807 deaths from hepatocellular carcinoma.
SUBJECTS AND METHODS
Study Participants
The Korean Cancer Prevention Study is a prospective cohort
study that was designed to assess risk factors for mortality,
incidence, and hospital admission from cancer, with a follow-up
of 10 years. Information concerning the development of this
cohort from participants in the Korea Medical Insurance Corpo-
ration has been provided elsewhere (2). In brief, the cohort was
composed of government employees, teachers, and their depen-
dents who were insured by the Korea Medical Insurance Cor-
poration from 1992 through 1995, had at least one medical
examination, and completed a questionnaire during that time.
All insured workers are required to participate in biennial med-
ical examinations. In 1992, 94% of the insured workers com-
pleted the biennial examinations, and 95% completed the bien-
nial examinations in 1994; 37% (1993) and 24% (1995) of the
insured workers’ dependents completed biennial medical
examinations.
The Korean Cancer Prevention Study cohort includes
1 329 525 Koreans (846 907 men and 482 618 women) from 30
to 95 years of age who met the above selection criteria. Of the
study participants, 784 870 (59.0%) were enrolled in 1992,
367 903 (27.7%) in 1993, 98 417 (7.4%) in 1994, and 78 335
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(5.9%) in 1995. Of the 1 329 525 participants, 3719 who re-
ported a history of any form of cancer at enrollment and 1483
who died from cancer before the start of follow-up were ex-
cluded. We further excluded the following numbers of partici-
pants because of missing information: 9619 on alcohol drinking,
17 108 on fasting serum glucose level, and 14 484 on weight or
height. The final sample size was 1 283 112. Of these partici-
pants, data on HBsAg status were available for 605 844 (47.2%).
Data Collection
The biennial examinations followed a standard procedure and
were conducted by medical staff at local hospitals. On the 1992,
1993, 1994, and 1995 questionnaires, participants were asked to
describe their smoking habits, along with other health habits,
including alcohol consumption. The completed questionnaires
were reviewed by trained staff and then entered into a database.
The data were checked further during analysis.
Based on questionnaire responses at the baseline examina-
tion, participants were classified as “current smokers” if they
reported smoking currently for at least 1 year, “never smokers”
if they had never smoked, and “ex-smokers” if they had smoked
but quit.
Alcohol consumption per day was categorized as follows: not
drinking (0 g), light drinking (1–24.9 g), moderate drinking
(25–49.9 g), heavy drinking (50–99 g), and very heavy drinking
(99.9 g or more). Total daily alcohol consumption was expressed
as number of glasses per week in relation to Korea’s most
popular alcoholic beverage, “Soju.” One glass of Soju contains
about 12 g of ethanol.
Obesity was also examined as a risk factor. We used the
World Health Organization standard body mass index (BMI)
cutpoints for Asians: 18.5, 18.5–22.9, 23.0–24.9, and 25.0
kg/m2) (3).
Fasting serum glucose; liver enzymes, including alanine ami-
notransferase and aspartate aminotransferase; and HBsAg were
detected in serum using enzymatic assays (Boehringer Mann-
heim, Germany) on a Hitachi 737 autoanalyzer. Serum HBsAg
was tested by radioimmunoassay or reverse passive hemagglu-
tination in hospital laboratories (Ausria II, Abbott, North Chi-
cago, IL, USA) (4).
The median follow-up period was 10 years, from January 1,
1993, to December 31, 2002. The exact dates of completion of
the survey form were not recorded. Consequently, follow-up
accrual began on January 1 of the calendar year following the
year in which the survey form was completed. Persons who
completed a survey but died in the same calendar year were
excluded.
Because the study involved routinely collected medical data,
it was not necessary to obtain individual participant consent. The
study was approved by the Institutional Review Boards of Yon-
sei University and the Johns Hopkins Bloomberg School of
Public Health.
Cancer Outcomes
The principal outcome variable was mortality from hepato-
cellular carcinoma. Mortality outcomes were ascertained from
death certificates. A computerized search of death certificate
data from the National Statistical Office in Korea was performed
using the unique identification number assigned at birth. Causes
of death were assigned at the hospitals by trained abstractors.
The analysis is limited to those deaths assigned to C22.0, pri-
mary hepatocellular carcinoma, in the 10th revision of the In-
ternational Classification of Diseases (5). We excluded all other
cancers coded to liver and intrahepatic bile ducts (C22.1–C22.9).
Statistical Analysis
Age-adjusted death rates were calculated for each category of
smoking, drinking, and HBsAg carrier status and were directly
standardized to the age distribution of the Korean national pop-
ulation in 1995. We also used Cox proportional hazards model-
ing to compute relative risks (RR) and 95% confidence intervals
(CIs) and to adjust for other potential risk factors (6). The
proportionality assumption was verified by inspection of hazard
plots. Because liver cancer incidence varies steeply with age, we
used linear and quadratic trends for age. Indicator variables were
used for smoking and alcohol use. To calculate the population-
attributable risk for HBsAg positivity, cigarette smoking, any
alcohol use, and the presence of diabetes mellitus, we used
Levin’s formula (7) with generalization to the two strata of
smoking status (8). We used the adjusted relative risk values to
calculate population-attributable risk. All statistical tests were
two-sided, and statistical significance was determined at P.05.
RESULTS
The population was mostly middle-aged, with approximately
twice as many men as women (Table 1). The population had a
low BMI on average, with 23.9% of men and 26.9% of women
at25 kg/m2 and 0.8% of men and 2.5% of women30 kg/m2.
Both smoking and alcohol use were substantially more common
in men than in women. At baseline, 9.4% of 478 189 men and
6.5% of 127 655 women for whom HBsAg status was available.
Most of the cohort was followed for at least 9 years. A total of
3807 deaths were coded as primary carcinoma of the liver for the
follow-up period of 1993–2002.
Table 1. Baseline characteristics of men and women in the Korean Cancer
Prevention Study, 1992–1995
Characteristic*
Men
(n  823 158)
Women
(n  459 954)
Age, y 45.2 11.1 49.5 12.1
Body mass index, kg/m2 23.2  2.6 23.2 3.3
Fasting serum glucose, mg/dL 92.8  25.1 90.6 24.3
Alcohol consumption, g/day 17.2 32.2 0.2 1.9
Alanine aminotransferase, U/L 26.5 17.3 22.4 9.7
Aspartate aminotransferase, U/L 26.1 21.6 19.3 11.8
Conditions, %
HBsAg positive† 9.4 6.5
Diabetes‡ 5.0 4.4
Any alcohol use 76.3 14.2
Smoking status
Never smokers 20.8 93.8
Ex smoker 20.7 2.1
Current smokers 58.5 4.1
Liver dysfunction§ 27.5 14.1
*Data are means  standard deviation or percentage.
†The data on hepatitis B surface antigen (HBsAg) are from 478 189 men and
127 655 women.
‡Defined as fasting blood glucose value of at least 126 mg/dL.
§Alanine aminotransferase 30 U/L or aspartate aminotransferase 35 U/L.
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Risk Factors for Hepatocellular Carcinoma
Table 2 shows the age-adjusted rates and the relative risk of
hepatocellular carcinoma death in men in relation to smoking,
alcohol use, diabetes, and HBsAg status. The findings show that
smoking was associated with an increased risk of hepatocellular
carcinoma, particularly among current smokers. Considering
current smokers only, we examined dose-response relationships
with number of cigarettes smoked per day and number of years
of smoking. The relative risk for hepatocellular carcinoma did
not increase with amount of smoking. However, for duration of
smoking, with 1–9 years as the reference category, statistically
significant increases were evident for smokers of 20–29 years
(RR  1.4; 95% CI  1.1 to 1.7) and 30 years (RR  1.4;
95% CI  1.1 to 1.8); this pattern was unchanged with stratifi-
cation by HBsAg status. Relative risk increased with increasing
alcohol consumption. For example, compared with never smok-
ers who were nondrinkers, the relative risk of hepatocellular
carcinoma for current smokers who smoked for 30 years and
drank 100 g/day of alcohol was estimated to be 2.5 (95% CI 
1.3 to 3.5). Risk was also higher among HBsAg-positive partic-
ipants, among whom the relative risk of hepatocellular carci-
noma was 24.3 (95% CI 21.9 to 26.9) compared with HBsAg-
negative participants. When HBsAg status was adjusted for in
the Cox model, the relative risks associated with smoking and
alcohol consumption did not change. BMI was not associated
with risk (data not shown).
Data were available for fewer women, and the analyses that
were carried out for men could therefore not be fully replicated
(Table 3). Smoking and alcohol consumption were associated
with increased relative risk of hepatocellular carcinoma in
women, but the estimates had wide confidence intervals. Being
HBsAg positive was strongly associated with risk for hepatocel-
lular carcinoma in women, with an estimated effect much higher
than that for men (RR  54.4; 95% CI  24.8 to 119.5). The
interaction of sex with HBsAg status in determining hepatocel-
lular carcinoma risk was statistically significant (P  .01).
We explored patterns of effect modification among smoking,
alcohol use, and HBsAg status using the Cox proportional haz-
ards model in men. Table 4 shows the age- and diabetes-adjusted
relative risk estimates for the strata defined by pairs of three
variables: HBsAg status, smoking, and alcohol intake. For
smoking and HBsAg, the pattern of relative risk estimates sug-
gested a possibly multiplicative or greater combined effect; the
interaction between HBsAg and alcohol was possibly additive.
The interaction between smoking and HBsAg was positive but
not statistically significantly elevated. That is, risk of hepatocel-
lular carcinoma was similar in smokers only, drinkers only, and
in smokers and drinkers. We also found no evidence for inter-
action of diabetes with HBsAg, smoking, and alcohol use (data
not shown).
We further explored the independent and joint effects of
smoking and alcohol consumption on risk of hepatocellular
carcinoma mortality with stratification by HBsAg status. No
statistically significant interaction among the factors was ob-
served (Fig. 1). We estimated the population-attributable risks
due to HBsAg positivity, cigarette smoking, and any alcohol use
as 66.7% (95% CI 64.4% to 69.1%), 25.1% (95% CI 18.0%
to 31.9%), and 4.6% (95% CI  0% to 10.9%), respectively.
DISCUSSION
In this large prospective cohort study of Korean men and
women, we found that cigarette smoking, alcohol drinking, and
HBsAg seropositivity were independent risk factors for hepato-
cellular carcinoma in both men and women. No interaction
among these three risk factors was observed.
Smoking has been extensively investigated as a risk factor for
hepatocellular carcinoma (1) and a range of associations, from
no association to relative risk estimates of 2, has been ob-
served. However, the IARC recently classified smoking as a
cause of hepatocellular carcinoma (1) based on the carcinogenic
potential of several compounds in tobacco smoke and the role
that the liver plays in the metabolism of these compounds (9), a
Table 2. Age-adjusted mortality rates per 100 000 and relative risks of mortality from hepatocellular carcinoma in men in the Korean Cancer Prevention Study
(1993–2002)*
Characteristic
All† Subjects with HBsAg data‡
No. Rate RR (95% CI) No. Rate RR (95% CI)
Smoking
Never smoker 557 32.8 1.0 (referent) 387 48.8 1.0 (referent)
Ex-smoker 840 52.4 1.2 (1.1–1.4) 515 54.3 1.1 (1.0 to 1.3)
Current smoker 1944 43.4 1.4 (1.3–1.6) 1354 54.4 1.5 (1.3 to 1.7)
Alcohol intake, g
0 1074 48.1 1.0 (referent) 683 63.9 1.0 (referent)
1–24.9 1704 38.3 1.0 (0.9 to 1.1) 1076 46.0 1.0 (0.9 to 1.1)
25–49.9 324 48.1 1.0 (0.9 to 1.2) 279 65.2 1.1 (0.9 to 1.3)
50–99.9 170 46.3 1.1 (0.9 to 1.4) 153 64.2 1.2 (1.0 to 1.5)
100 69 51.0 1.4 (1.0 to 1.8) 65 70.0 1.5 (1.2 to 2.0)
Diabetes§
No 2960 37.3 1.0 (referent) 2006 47.1 1.0 (referent)
Yes 381 62.2 1.7 (1.5 to 2.0) 250 82.3 1.9 (1.6 to 2.2)
HBsAg
Negative 734 21.8 1.0 (referent)
Positive 1522 405.2 24.3 (21.9 to 26.9)
*Risk ratios (RRs) and 95% confidence intervals (CIs) from multivariable Cox proportional models.
†Adjusted for age, age squared, smoking, alcohol use, and diabetes.
‡Adjusted for variables in “All” and includes hepatitis B surface antigen (HBsAg), which was measured in 478 189 men and 127 655 women.
§The referent category is a fasting serum glucose level of 126 mg/dL; diabetes is defined as a fasting serum glucose level of 126 mg/dL and/or medication.
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systematic review of the epidemiologic evidence, and a deter-
mination that the association of smoking with hepatocellular
carcinoma could not be explained by confounding from alcohol
consumption or hepatitis B (1). Our results are consistent with a
causal role of cigarette smoking in the etiology of hepatocellular
carcinoma. We estimated that 25% of cancer diagnoses were
attributable to smoking.
We readily confirmed the very strong association of hepatitis
B on hepatocellular carcinoma risk (10). The magnitude of the
increased risk was similar to that seen in other studies, and we
observed a statistically significantly greater risk in women than
in men. Previously, only one study reported a difference by sex
in risk of hepatocellular carcinoma associated with hepatitis B.
This study, a cohort study in China, reported that the relative risk
for hepatocellular carcinoma in women was nearly twice that in
men, although the interaction with sex was not statistically
significant (P  .11) (11). We documented a similar magnitude
of risk by sex. Given the lack of interaction of hepatitis B
seropositivity with other risk factors that are more frequent in
males, particularly alcohol consumption and smoking, future
research into the mechanism by which hepatitis B increases
mortality from hepatocellular carcinoma might be directed at
hormonal or other factors associated with sex.
Our results also indicate that heavy alcohol consumption
increases the risk for liver cancer. This observed association is in
agreement with those of most recent studies on this topic
(12–16).
Our study has several potential limitations that arise pri-
marily from the use of data collected as part of an insurance
plan. The questionnaires provide self-reported smoking and
alcohol use information without validation. In addition, death
certificate attribution of cause of death to hepatocellular car-
cinoma is subject to misclassification (17) with the potential
for miscoding metastatic tumors to the liver as primary can-
cers of the liver. Although false-positives undoubtedly occur
with this classification method, we do not think that our
findings can be explained by inadequate specificity of death
certificate classification, because we would anticipate a gen-
eral bias toward the null from misclassification unless it were
differential by exposure.
Table 4. Relative risk of mortality from hepatocellular carcinoma among men in the Korean Cancer Prevention Study (1993–2002)*
Variable 1 Variable 2 Person-years No. RR (95% CI)
HBsAg Smoking status
Negative Never smoker 846 937 136 1.0 (referent)
Negative Ever smoker 3368 042 604 1.1 (0.9 to 1.4)
Positive Never smoker 92 132 256 18.8 (14.7 to 24.0)
Positive Ever smoker 345 114 1284 29.0 (23.7 to 35.4)
HBsAg Alcohol intake
Negative 0–24.9 g/day 3274 530 570 1.0 (referent)
Negative 25 g/day 958 448 170 1.2 (1.0 to 1.4)
Positive 0–24.9 g/day 346 988 1210 24.6 (21.9 to 27.7)
Positive 25 g/day 90 258 330 27.7 (23.7 to 32.4)
Alcohol intake Smoking status
0–24.9 g/day Never smoker 831 143 336 1.0 (referent)
0–24.9 g/day Ever smoker 2790 375 1,440 1.5 (1.3 to 1.7)
25 g/day Never smoker 125 926 56 1.5 (1.1 to 2.0)
25 g/day Ever smoker 922 781 444 1.6 (1.4 to 1.9)
*Risk ratio (RRs) and 95% confidence intervals (CIs) from multivariable Cox proportional models after adjusting for age, smoking, alcohol intake, hepatitis B
antigen (HBsAg), and diabetes.
Table 3. Age-adjusted mortality rates and relative risks of mortality from hepatocellular carcinoma in women in the Korean Cancer Prevention Study (1993–
2002)*
Characteristic
All† Subjects with HBsAg data‡
No. Rate RR (95% CI) No. Rate RR (95% CI)
Smoking
Never smoker 399 9.1 1.0 (referent) 45 4.8 1.0 (referent)
Ex-smoker 27 14.3 1.3 (0.8 to 2.1) 1 12.8 NE
Current smoker 40 8.5 1.1 (0.8 to 1.7) 0 0 NE
Alcohol intake
Nondrinker 397 7.8 1.0 (referent) 36 4.5 1.0 (referent)
Ever drinker 69 8.8 1.2 (0.9 to 1.5) 10 6.1 2.0 (0.9 to 4.5)
Diabetes§
No 425 9.1 1.0 (referent) 44 4.7 1.0 (referent)
Yes 41 11.0 1.7 (1.2 to 2.6) 2 8.6 NE
HBsAg
Negative 9 1.2 1.0 (referent)
Positive 37 58.4 54.4 (24.9 to 119.5)
*Risk ratio (RRs) and 95% confidence intervals (CIs) from multivariable Cox proportional models.
†Adjusted for age, age squared, smoking, alcohol use, and diabetes.
‡Adjusted for variables in “All” and hepatitis B surface antigen (HBsAg), which was measured in 478 189 men and 127 655 women. NE  not estimated due
to the low number of participants in this group.
§The referent category is a fasting serum glucose level 126 mg/dL; diabetes is defined as a fasting serum glucose level 126 mg/dL and/or medication.
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To gain some insight into the potential degree of misclassi-
fication, we examined the proportion of incident liver cancer
case patients who died and had their deaths coded to primary
liver cancer during the follow-up interval. For those 2449 pa-
tients with incident cancer diagnosed through 1997, 73% died
and had their death coded to primary liver cancer by the end of
follow-up in 2002. Independent cancer registry data show 5-year
survival of 10.5% for incident liver cancer (18). Given this high
mortality rate and the high rate of coding of death in incident
liver cancer cases to liver cancer in our data, we consider that
misclassification of outcome is not an issue in interpreting our
findings.
In addition, our study cohort is not representative of all
Koreans because it includes employed persons and their families
and, consequently, may under-represent heavy users of alcohol
and tobacco. However, follow-up should be almost complete
because of our use of record linkage with unique personal
identifiers to national databases; thus, any loss to follow-up
should not introduce bias.
This study also had several strengths. A particular strength
was the large number of participants, which allowed for the
exploration of interactions among these well-established risk
factors. The array of interactions has been addressed in a number
of previously published studies, without consistent findings for
effect modification among these agents. In its most recent re-
view, the IARC Working Group (1) did not find strong evidence
that the risk of hepatocellular carcinoma due to smoking was
modified by either alcohol consumption or hepatitis. However,
risk modification was not assessed formally in most of the
studies, and power for assessing effect modification was limited
for most of them. Evidence for synergism between smoking and
alcohol has been noted in several case–control studies (19,20).
For smoking and hepatitis, synergism was found in two case–
control studies (20,21), but two prospective cohort studies
(11,22) did not find a synergistic interaction. The same two
prospective cohort studies (11,22) reported that there was no
interaction between alcohol consumption and hepatitis B in
hepatocellular carcinoma risk. Interpretation of these findings
from a small number of studies needs to be guarded, given their
methodologic limitations. Our study provides further evidence
against interaction of smoking with alcohol consumption, smok-
ing with hepatitis B, and alcohol with hepatitis B in determining
risk for hepatocellular carcinoma.
Hepatocellular carcinoma has a well-established suite of en-
vironmental risk factors, both infectious and noninfectious. Ex-
posures to these risk factors vary around the world, but exposure
to each of the key risk factors can potentially be controlled and
the majority of hepatocellular carcinoma deaths avoided. Our
analyses of Koreans show the potential for prevention and the
need to implement strong prevention programs: the multivari-
able adjusted population-attributable risks for hepatitis B
(66.7%) and smoking (25.1%) accounted for most cases, and we
found little indication of a joint contribution. In Korea, relatively
high rates of the major known risk factors for hepatocellular
carcinoma mortality—HBsAg seropositivity, cigarette smoking,
and alcohol drinking—exist, emphasizing the need for mass
immunization against hepatitis B virus and antismoking and
antidrinking programs. Since 1995, the Korean government has
carried out a program of vaccination against hepatitis B, and the
prevalence of HBsAg seropositivity is now falling (23).
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